# Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

> **NCT00364702** · PHASE2 · COMPLETED · sponsor: **Shaare Zedek Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** methylphenidate

## Key facts

- **NCT ID:** NCT00364702
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364702, "Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00364702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*